The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/37762
StudyName: Eligibility Breast Cancer NCT00912444
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 22.08.2019
License: Creative Commons BY 4.0

----

Description: 
Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00912444
